Successful erlotinib rechallenge after erlotinib-induced interstitial lung disease.

Autor: Dallas JL, Jantz MA, Lightsey JL, Sonntag C, Kaye FJ, Dallas, Jennifer L, Jantz, Michael A, Lightsey, Judith L, Sonntag, Christopher, Kaye, Frederic J
Zdroj: Journal of Thoracic Oncology; 2011 Jun, Vol. 6 Issue 6, p1142-1143, 2p
Databáze: Complementary Index